TGFB1 and breast carcinoma: Since the TGF-β–SMAD pathway is associated with cancer metastasis in models such as MDA-MB-231 breast cancer cells and LKB1 can prevent the activation of TGF-β–SMAD signaling, we looked at EMT markers (22).